Evidence map›Paper›PMID 33980709›Full record

ArticleNeurology2021

Intra-arterial Melphalan for Neurologic Non-Langerhans Cell Histiocytosis.

Jasmine H Francis, Y Pierre Gobin, Ruham Alshiekh Nasany, Jared Knopman, Gary A Ulaner, Katherine S Panageas, Vaios Hatzoglou, Kim Salvaggio, David H Abramson, Athos Patsalides and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Neurological Manifestations of Histiocytic Disorders.Current neurology and neuroscience reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jasmine H FrancisFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.ORCID 0000-0002-7637-3108
Y Pierre GobinFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
Ruham Alshiekh NasanyFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.ORCID 0000-0001-6600-3181
Jared KnopmanFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
Gary A UlanerFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
Katherine S PanageasFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
Vaios HatzoglouFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
Kim SalvaggioFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
David H AbramsonFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
Athos PatsalidesFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA.
Eli L DiamondFrom the Ophthalmic Oncology Service (J.H.F., D.H.A.) and Departments of Neurology (R.A.N., E.L.D.), Radiology (G.A.U., V.H.), and Epidemiology and Statistics (K.P.), Memorial Sloan Kettering Cancer Center; Department of Neurosurgery (Y.P.G., J.K., K.S., A.P.), Weill Cornell Medical Center, New York; and Molecular Imaging and Therapy (G.A.U.), Hoag Family Cancer Institute, Newport Beach, CA. diamone1@mskcc.org.ORCID 0000-0001-5456-5961

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntineoplastic Agents, AlkylatingFemaleHistiocytosis, Non-Langerhans-CellHistiocytosis, SinusHumansInfusions, Intra-ArterialMaleMelphalanMiddle AgedAntineoplastic Agents, AlkylatingMelphalan

Identifiers

PMID33980709
PMCPMC8205455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.